PLX4032

A drug used to treat Erdheim-Chester disease (a very rare type of histiocytosis) and advanced melanoma. It is used in patients whose disease has a mutated (changed) form of a gene called BRAF. It is also being studied in the treatment of other types of cancer. PLX4032 blocks certain proteins made by the mutated BRAF gene, which may help keep cancer cells from growing. It is a type of kinase inhibitor and a type of targeted therapy agent. Also called BRAF (V600E) kinase inhibitor RO5185426, RG7204, vemurafenib, and Zelboraf.

• Dailymed label info on PLX4032
• FDA PLX4032

PLX4032 Resources
Need Help Finding a Doctor? Need help finding a doctor or specialist anywhere in the world? Explore our world directory. WikiMD's DocFinder can assist you in locating millions of physicians.	Medical Knowledge Access the latest research - Most recent articles Ongoing trials.

Translate to: East Asian 中文, 日本, 한국어, South Asian हिन्दी, Urdu, বাংলা, తెలుగు, தமிழ், ಕನ್ನಡ,
Southeast Asian Indonesian, Vietnamese, Thai, မြန်မာဘာသာ, European español, Deutsch, français, русский, português do Brasil, Italian, polski